Search

everythinglearnresearchcommunity

for

Search:↓

Possible link between androgens and COVID-19 severity; more research needed.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Gut microbes significantly affect brain steroid levels.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

No treatment fully prevents hair loss from chemotherapy yet.